PharmaShots | Incisive News in 3 Shots

Subscribe Now

European Commission Approval

Sanofi's Dupixent (dupilumab) Receives EC's Approval for Children with Severe Atopic Dermatitis

Sanofi's Dupixent (dupilumab) Receives EC's Approval for Children with Severe Atopic Dermatitis

December 1, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us